亚盛医药-B(06855)授出受限制股份单位及购股权

智通财经04-20

智通财经APP讯，亚盛医药-B(06855)发布公告，截至本公告日期，已向2022年受限制股份单位计划的3名选定人士(2022年选定人士)授出69.63万份受限制股份单位(2022年奖励)，相当于 69.63万股股份(2022年进一步授出)，其中向本公司执行董事兼首席执行官杨大俊博士(杨博士)授出39.38万份受限制股份单位;向本公司首席医学官兼主要股东翟一帆博士(翟博士)授出28.39万份受限制...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2628721474?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-20 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628721474","market":"sh","top_or_hot":-1,"title":"亚盛医药-B(06855)授出受限制股份单位及购股权","media":"智通财经","content":"<div>\n<p>智通财经APP讯，亚盛医药-B(06855)发布公告，截至本公告日期，已向2022年受限制股份单位计划的3名选定人士(2022年选定人士)授出69.63万份受限制股份单位(2022年奖励)，相当于 69.63万股股份(2022年进一步授出)，其中向本公司执行董事兼首席执行官杨大俊博士(杨博士)授出39.38万份受限制股份单位;向本公司首席医学官兼主要股东翟一帆博士(翟博士)授出28.39万份受限制...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1430985.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亚盛医药-B(06855)授出受限制股份单位及购股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亚盛医药-B(06855)授出受限制股份单位及购股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-20 22:42 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1430985.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，亚盛医药-B(06855)发布公告，截至本公告日期，已向2022年受限制股份单位计划的3名选定人士(2022年选定人士)授出69.63万份受限制股份单位(2022年奖励)，相当于 69.63万股股份(2022年进一步授出)，其中向本公司执行董事兼首席执行官杨大俊博士(杨博士)授出39.38万份受限制股份单位;向本公司首席医学官兼主要股东翟一帆博士(翟博士)授出28.39万份受限制...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1430985.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AAPG","symbol_name":"亚盛医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1430985.html","article_id":"2628721474","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2628721474","pubTimestamp":1776696140,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，亚盛医药-B 发布公告，截至本公告日期，已向2022年受限制股份单位计划的3名选定人士授出69.63万份受限制股份单位，相当于 69.63万股股份，其中向本公司执行董事兼首席执行官杨大俊博士(杨博士)授出39.38万份受限制股份单位;向本公司首席医学官兼主要股东翟一帆博士(翟博士)授出28.39万份受限制股份单位;及向本公司1名高级管理人员授出1.86万份受限制股份单位。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AAPG":"亚盛医药","06855":"亚盛医药","BK1161":"生物科技","BK1574":"生物医药B类股","BK4139":"生物科技"},"translate_title":"Grant of RSUs and share options by Ascentage Pharma-B (06855)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AAPG":1.5,"06855":1.5},"content_text":"智通财经APP讯，亚盛医药-B(06855)发布公告，截至本公告日期，已向2022年受限制股份单位计划的3名选定人士(2022年选定人士)授出69.63万份受限制股份单位(2022年奖励)，相当于 69.63万股股份(2022年进一步授出)，其中向本公司执行董事兼首席执行官杨大俊博士(杨博士)授出39.38万份受限制股份单位;向本公司首席医学官兼主要股东翟一帆博士(翟博士)授出28.39万份受限制股份单位;及向本公司1名高级管理人员授出1.86万份受限制股份单位。截至本公告日期，本公司已根据首次公开发售后购股权计划的条款，向本公司执行董事兼首席执行官杨博士及本公司首席医学官兼主要股东翟博士进一步授出51.32万份购股权(2022年购股权)，赋予购股权持有人权利于行使该等购股权时认购合共51.32万股本公司普通股(购股权进一步授出)，惟须待杨博士及翟博士接纳后方可作实，其中29.82万份购股权授予杨博士;及21.5万份购股权授予翟博士。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2628721474","isCrawlerRequest":true}